Biotechnology / Cancer Diagnostics
Jobs at DELFI Diagnostics, Inc.
About DELFI Diagnostics, Inc.
DELFI Diagnostics develops blood-based liquid biopsy tests for early cancer detection using fragmentomics and machine learning.
- Industry
- Biotechnology / Cancer Diagnostics
- Open roles
- 9
Open positions
Explore roles at DELFI Diagnostics, Inc.
Showing 9 of 9 roles
DELFI Diagnostics, Inc.
DELFI Diagnostics develops blood-based liquid biopsy tests for early cancer detection using fragmentomics and machine learning.
DELFI Diagnostics, Inc.
DELFI Diagnostics develops blood-based liquid biopsy tests for early cancer detection using fragmentomics and machine learning.
DELFI Diagnostics, Inc.
DELFI Diagnostics develops blood-based liquid biopsy tests for early cancer detection using fragmentomics and machine learning.
DELFI Diagnostics, Inc.
DELFI Diagnostics develops blood-based liquid biopsy tests for early cancer detection using fragmentomics and machine learning.
DELFI Diagnostics, Inc.
DELFI Diagnostics develops blood-based liquid biopsy tests for early cancer detection using fragmentomics and machine learning.
DELFI Diagnostics, Inc.
DELFI Diagnostics develops blood-based liquid biopsy tests for early cancer detection using fragmentomics and machine learning.
DELFI Diagnostics, Inc.
DELFI Diagnostics develops blood-based liquid biopsy tests for early cancer detection using fragmentomics and machine learning.
DELFI Diagnostics, Inc.
DELFI Diagnostics develops blood-based liquid biopsy tests for early cancer detection using fragmentomics and machine learning.
DELFI Diagnostics, Inc.
DELFI Diagnostics develops blood-based liquid biopsy tests for early cancer detection using fragmentomics and machine learning.